2nd Edelris Symposium on Affinity Selection-Mass Spectrometry in Drug Discovery

High Throughput Technology for Hit Generation

 Virtual Event    June 8-9, 2022

Programme



16:00

Opening & Introduction

Dr Jean-Yves ORTHOLAND
EDELRIS, Lyon, France
16:05

Start of sessions

Session 1
Session 1
16:05
PL01 - Using Affinity-selection MS to Find Compounds that Disrupt RNA Structure and X-Chromosome Inactivation via Xist
Dr Elliott B. NICKBARG
MERCK RESEARCH LABORATORIES, Boston, United States
16:40
PL02 - Challenges and Opportunities in the Application of Affinity Selection Mass Spectrometry in Early Drug Discovery
Dr Manuel Francisco MOLINA-MARTIN
LILLY LABORATORIES, Madrid, Spain
17:15
PL03 - Utilizing Mass Spectrometry to Discover RNA-binding Small Molecules
Dr Scott RUSIN
ARRAKIS THERAPEUTICS, Waltham, MA, United States
17:50
Break
18:00
Roundtable discussion & Closing remarks
Dr Elliott B. NICKBARG
MERCK RESEARCH LABORATORIES, Boston, United States
Dr Scott RUSIN
ARRAKIS THERAPEUTICS, Waltham, MA, United States
Dr Manuel Francisco MOLINA-MARTIN
LILLY LABORATORIES, Madrid, Spain
Dr Didier ROCHE
EDELRIS, Lyon, France
16:00

Opening remarks Day 2

Dr Allen ANNIS
AILERON THERAPEUTICS, Cambridge, United States
16:05

Start of sessions

Session 2
Session 2
16:05
PL04 - Affinity Selection-Mass Spectrometry for Oligonucleotides, Proteins, Cells, and Animals
Prof. Bradley Lether PENTELUTE
MASSACHUSETTS INSTITUTE OF TECHNOLOGY, Cambridge, MA, United States
16:40
PL05 - Affinity Selection Mass Spectrometry (ASMS) for Experimental Target Tractability Assessment (eTA)
Dr Lauren KUSTIGIAN
GSK, Collegeville, PA, United States
17:15
PL06 - Difficulties and Solutions Along the ASMS Data Analysis Pathway
Dr Mark SPEARS
VIRSCIDIAN, Cary, NC, United States
17:50
Break
18:00
Roundtable discussion & Closing remarks
Prof. Bradley Lether PENTELUTE
MASSACHUSETTS INSTITUTE OF TECHNOLOGY, Cambridge, MA, United States
Dr Lauren KUSTIGIAN
GSK, Collegeville, PA, United States
Dr Mark SPEARS
VIRSCIDIAN, Cary, NC, United States
Dr Allen ANNIS
AILERON THERAPEUTICS, Cambridge, United States